FASN and hyperlipidemia: DBP can activate the PPARα signaling pathway and affect the expression of fatty acid synthase, sterol regulatory element binding proteins, and glycerol-3-phosphate acyltransferase to cause hyperlipidemia and abnormal liver function [64].